The data demonstrated that there were significant differences between tumor tissues and their respective control tissues in 15 distinct cancers, of which the expression pattern of FUNDC2 mRNA in 8 tumor tissues was lower than the controls in most pan-cancers, especially BLCA (Fig 1). Here, FUNDC2 is linked to cancer.